TTC39B 抗体 (AA 129-682) (Fluoro647)
Our Local Distributor
北京 101111
Quick Overview for TTC39B 抗体 (AA 129-682) (Fluoro647) (ABIN8045981)
抗原
See all TTC39B 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 129-682
-
原理
- Anti-TTC39B Antibody Fluoro647 Conjugated
-
交叉反应 (详细)
- No cross-reactivity with other proteins
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human TTC39B recombinant protein (Position: K129-D682).
-
亚型
- IgG
-
-
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- TTC39B (Tetratricopeptide Repeat Domain 39B (TTC39B))
-
别名
- TTC39B
-
背景
-
Background: Tetratricopeptide repeat protein 39B is a protein that in humans is encoded by the TTC39B gene. TTC39B protein contains two TPR repeats (aa 39 3-426 and 626 -659). TCC39B protein is the product of a high density lipoprotein (HDL) gene that promotes the ubiquitination and degradation of liver X receptor (LXR). TTC39B null or deficient mice challenged with high fat/cholesterol/bile salt diet exhibit increased LX R protein and target gene expression. TTC39B deficiency is reported to stabilize LXR by reducing its polyubiquitination and proteasomal degradation. Hence it reduces the incidence of atherosclerosis and steatohepatitis. TTC39B deficiency mice display higher levels of HDL and Apoplipoprotein A-1 and lower levels of hepatic triglyceride synthesis.However it does not affect glucose tolerance or hepatic gluconeogenesis.
Gene Full Name: tetratricopeptide repeat domain 39B
-
基因ID
- 158219
-
UniProt
- Q5VTQ0
抗原
-